explore -WSS

explore

author：leisure time 2025-09-27 09:54:07 - browse：427

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Editas, Vertex strike deal on CRISPR

leisure time

knowledge

WSS

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Obesity drug from Roche shows promise in early study

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Galapagos to make CAR

Free medical tuition alone isn't enough to close gaps in primary care

leisure time

explore

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cherokee Nation medical school graduates its first class

DIEP, the 'gold standard' of breast reconstruction, is under threat

Prime Medicine, Myeloid Therapeutics clash over genome

Psychedelics group wrestles with new pharma identity

Free medical tuition alone isn't enough to close gaps in primary care

Continuity nursing helped my family in our darkest PICU moments

Medicare drug price negotiation hasn't dried up venture capital

Sports medicine is finally prioritizing gender equality

Lilly’s weekly insulin works as well as daily products, new studies show

focus

Medicare drug price negotiation hasn't dried up venture capital

Virtual care provider acquires bankrupt Pear's prescription apps

Drinking less cuts risk of oral cavity, esophageal cancer: Report

HCA sued by state AG for quality issues at Mission Health

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

How to keep neuroscience’s past racism from being its future

leisure time

leisure time

knowledge

focus